Cargando…

SARS-CoV-2 testing in travellers: Can we be smarter?

Detalles Bibliográficos
Autor principal:	Brophy, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Joule Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800472/ https://www.ncbi.nlm.nih.gov/pubmed/35012952 http://dx.doi.org/10.1503/cmaj.80779

Ejemplares similares

Apoptosis induced by SARS-CoV-2: can we target it?
por: Donia, Ahmed, et al.
Publicado: (2021)

Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China
por: Liu, Jingtao, et al.
Publicado: (2020)

Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China
por: Akhmetzhanov, Andrei R.
Publicado: (2020)

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan
por: Fujino, Takahisa, et al.
Publicado: (2021)

Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
por: Donia, Ahmed, et al.
Publicado: (2021)

Countering more virulent SARS-CoV-2 variants will require a smarter pandemic response
por: Patrick, Kirsten
Publicado: (2021)

How can we interpret SARS-CoV-2 antibody test results?
por: Føns, Sofie, et al.
Publicado: (2021)

Monitoring International Travelers Arriving in Hong Kong for Genomic Surveillance of SARS-CoV-2
por: Gu, Haogao, et al.
Publicado: (2022)

SARS CoV-2 aerosol: How far it can travel to the lower airways?
por: Islam, Mohammad S., et al.
Publicado: (2021)

Repeated Testing in SARS-CoV-2 Infection
por: Lippi, Giuseppe, et al.
Publicado: (2020)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy
por: Maggi, Fabrizio, et al.
Publicado: (2021)

Unreported SARS-CoV-2 Home Testing and Test Positivity
por: Park, Soo, et al.
Publicado: (2023)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Hearing Loss in SARS-CoV-2: What Do We Know?
por: Saniasiaya, Jeyasakthy
Publicado: (2021)

Co-testing a single sputum specimen for TB and SARS-CoV-2
por: Genade, L. P., et al.
Publicado: (2023)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
por: Yue, Lei, et al.
Publicado: (2021)

In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020)

The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population
por: Stang, Andreas, et al.
Publicado: (2021)

You can: from smarter to wiser
por: Shenoy, Meera, et al.
Publicado: (2016)

Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022
por: Gu, Haogao, et al.
Publicado: (2022)

Can dried blood spots (DBS) contribute to conducting comprehensive SARS‐CoV‐2 antibody tests?
por: Thevis, Mario, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022)

Should we test asymptomatic children for SARS-CoV-2?
por: Cowan, Kirsty, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infections: What do we need to know?
por: Tan, Caixia, et al.
Publicado: (2020)

Airport Traveler Testing Program for SARS-CoV-2 — Alaska, June–November 2020
por: Ohlsen, Elizabeth C., et al.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Thermal treatment of nasopharyngeal samples before cobas SARS-CoV-2 testing
por: Pryce, Todd M., et al.
Publicado: (2021)

Design Driven Testing: Test Smarter, Not Harder
por: Stephens, M, et al.
Publicado: (2010)

SARS-CoV-2 Testing in India: Please Mind the Gaps
por: Mukherjee, Kanchan
Publicado: (2022)

SARS-CoV-2 diagnostic testing in Africa: needs and challenges
por: Adebisi, Yusuff Adebayo, et al.
Publicado: (2020)

Strengths and weaknesses of the diagnostic tests for SARS-CoV-2 infection()
por: Hernández-Pérez, José María, et al.
Publicado: (2020)

Serological testing for SARS-CoV-2: Advancements and future challenges
por: Alexopoulos, Harry, et al.
Publicado: (2023)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

The effects of SARS-CoV-2 on menstruation
por: Danesh, Laila, et al.
Publicado: (2021)

We Are Smarter Than Me: Crowdsourcing New Businesses
por: Libert, Barry
Publicado: (2010)

SARS-CoV-2 sensitivity limbo – How low can we go?
por: Patriquin, Glenn, et al.
Publicado: (2021)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_on2lild59bsiput2692lm1l6co